9th Dec 2015 09:20
LONDON (Alliance News) - Tiziana Life Sciences PLC Wednesday said it has appointed James Tripp as chief operating officer and head of Global Clinical Operations.
Tripp is not being appointed to the company's board. Tripp has previously held roles at Novo Nordisk AS and Regeneron Pharmaceuticals Inc.
Shares in Tiziana were up 3.2% at 209.07 pence Wednesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
TILS.L